Large-scale testing (Phase 3)Study completedNCT01429441
What this trial is testing
Ocriplasmin for Treatment for Symptomatic Vitreomacular Adhesion Including Macular Hole
Who this might be right for
Vitreomacular Adhesion Including Macular Hole
ThromboGenics 220